504 related articles for article (PubMed ID: 9677888)
1. Highly virulent pathogens--a post antibiotic era?
Domin MA
Br J Theatre Nurs; 1998 May; 8(2):14-8. PubMed ID: 9677888
[TBL] [Abstract][Full Text] [Related]
2. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
Henderson DK
Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S46-54: discussion S64-73. PubMed ID: 16813982
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
McDonald LC; Hageman JC
Nephrol News Issues; 2004 Oct; 18(11):63-4, 66-7, 71-2 passim. PubMed ID: 15551615
[TBL] [Abstract][Full Text] [Related]
4. Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms.
Henderson DK
Am J Med; 2006 Jun; 119(6 Suppl 1):S45-52; discussion S62-70. PubMed ID: 16735151
[TBL] [Abstract][Full Text] [Related]
5. Can antibiotic-resistant nosocomial infections be controlled?
Farr BM; Salgado CD; Karchmer TB; Sherertz RJ
Lancet Infect Dis; 2001 Aug; 1(1):38-45. PubMed ID: 11871409
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-resistant Staphylococcus aureus: perspectives on measures needed for control.
Edmond MB; Wenzel RP; Pasculle AW
Ann Intern Med; 1996 Feb; 124(3):329-34. PubMed ID: 8554229
[TBL] [Abstract][Full Text] [Related]
7. Vital Signs: Preventing Antibiotic-Resistant Infections in Hospitals - United States, 2014.
Weiner LM; Fridkin SK; Aponte-Torres Z; Avery L; Coffin N; Dudeck MA; Edwards JR; Jernigan JA; Konnor R; Soe MM; Peterson K; McDonald LC
MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(9):235-41. PubMed ID: 26963489
[TBL] [Abstract][Full Text] [Related]
8. Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci.
Kreman T; Hu J; Pottinger J; Herwaldt LA
Infect Control Hosp Epidemiol; 2005 Oct; 26(10):811-5. PubMed ID: 16276955
[TBL] [Abstract][Full Text] [Related]
9. Common approaches to the control of multidrug-resistant organisms other than methicillin-resistant Staphylococcus aureus (MRSA).
Hebert C; Weber SG
Infect Dis Clin North Am; 2011 Mar; 25(1):181-200. PubMed ID: 21316000
[TBL] [Abstract][Full Text] [Related]
10. Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.
Ofner-Agostini M; Varia M; Johnston L; Green K; Simor A; Amihod B; Bryce E; Henderson E; Stegenga J; Bergeron F; ; Gravel D
Am J Infect Control; 2007 Nov; 35(9):563-8. PubMed ID: 17980232
[TBL] [Abstract][Full Text] [Related]
11. Reconsidering contact precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Morgan DJ; Murthy R; Munoz-Price LS; Barnden M; Camins BC; Johnston BL; Rubin Z; Sullivan KV; Shane AL; Dellinger EP; Rupp ME; Bearman G
Infect Control Hosp Epidemiol; 2015 Oct; 36(10):1163-72. PubMed ID: 26138329
[TBL] [Abstract][Full Text] [Related]
12. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
13. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
[TBL] [Abstract][Full Text] [Related]
14. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force.
Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB; ;
Infect Control Hosp Epidemiol; 2007 Mar; 28(3):249-60. PubMed ID: 17326014
[TBL] [Abstract][Full Text] [Related]
15. Newer treatment options for skin and soft tissue infections.
Raghavan M; Linden PK
Drugs; 2004; 64(15):1621-42. PubMed ID: 15257625
[TBL] [Abstract][Full Text] [Related]
16. Improving hospital hygiene to reduce the impact of multidrug-resistant organisms in health care--a prospective controlled multicenter study.
Gerlich MG; Piegsa J; Schäfer C; Hübner NO; Wilke F; Reuter S; Engel G; Ewert R; Claus F; Hübner C; Ried W; Flessa S; Kramer A; Hoffmann W
BMC Infect Dis; 2015 Oct; 15():441. PubMed ID: 26493394
[TBL] [Abstract][Full Text] [Related]
17. Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients.
Jones RN
Am J Med; 1996 Jun; 100(6A):3S-12S. PubMed ID: 8678095
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
20. Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.
Polgreen PM; Beekmann SE; Chen YY; Doern GV; Pfaller MA; Brueggemann AB; Herwaldt LA; Diekema DJ
Infect Control Hosp Epidemiol; 2006 Mar; 27(3):252-6. PubMed ID: 16532412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
